Vision With Wings Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 9617 N. Metro Pkwy West, Ste. 1214, Phoeniz, AZ 85051 Phone: 602-870-3759 Fax: 866-627-0684 |
News Archive
Provectus Biopharmaceuticals, Inc. (PVCT), a development-stage oncology and dermatology biopharmaceutical company, today announced that it has received the official minutes from the Type C meeting held with the FDA's Division of Oncology Products 2 on December 16, 2013.
The WHO on Tuesday "said it is continuing to work with authorities from the Democratic Republic of the Congo (DRC) to stop an Ebola outbreak from spreading, with the number of detected cases having reached 46 in the past week," the U.N. News Centre reports.
OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, today announced positive interim analysis of data from 81 subjects in a Phase IV study of primary and locally recurrent squamous cell carcinoma of the head and neck (HNSCC) treated with OMS ElectroChemotherapy in Europe.
Genzyme Corporation and Arecor Limited today signed an agreement providing for extensive collaboration on developing advanced formulations for protein therapeutics. The agreement provides for a close working relationship between Genzyme and Arecor in developing stable, high strength formulations of labile biomolecules. This agreement is the result of a two year working relationship where Arecor has demonstrated their technologies offer an improvement over conventional approaches in protein formulation.
Planned Caesarean sections do not help to reduce the chances of a pregnant mother with Hepatitis C (HCV) transmitting the infection to her unborn baby, according to new scientific findings by the National Maternity Hospital in Dublin and University College Dublin.
› Verified 3 days ago